UK markets closed
  • NIKKEI 225

    30,323.34
    -188.37 (-0.62%)
     
  • HANG SENG

    24,667.85
    -365.36 (-1.46%)
     
  • CRUDE OIL

    72.58
    -0.03 (-0.04%)
     
  • GOLD FUTURES

    1,753.60
    -3.10 (-0.18%)
     
  • DOW

    34,751.32
    -63.07 (-0.18%)
     
  • BTC-GBP

    34,574.12
    -457.72 (-1.31%)
     
  • CMC Crypto 200

    1,209.85
    -23.43 (-1.90%)
     
  • ^IXIC

    15,181.92
    +20.39 (+0.13%)
     
  • ^FTAS

    4,051.44
    +12.00 (+0.30%)
     

Gene Berghoff Drops Lawsuit Against Envoy Medical

·1-min read

WHITE BEAR LAKE, Minn., September 15, 2021--(BUSINESS WIRE)--Envoy Medical® Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, today announced that a lawsuit filed against the Company by Gene Berghoff has been voluntarily dismissed with prejudice. Nothing was paid by the Company to Mr. Berghoff, and the parties will pay their own fees and costs.

"We are pleased that, after investigating his claims, Mr. Berghoff decided to drop his lawsuit," said Brent Lucas, CEO of Envoy Medical.

About Envoy Medical Corporation
Envoy Medical Corporation, headquartered in White Bear Lake, Minnesota, is a privately held hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance and ultimately quality of life. For more information, please visit: www.envoymedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210915005292/en/

Contacts

MEDIA CONTACT:
Tiffany Narváez
Merryman Communications
tiffany@merrymancommunications.com
310-658-4114

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting